MeSH tree: C01.925.782.600.550.200.163.500
The risk of developing long COVID has decreased significantly over the course of the COVID-19 pandemic, according to an analysis of data led by Washington University School of Medicine in St. Louis.
Jul 17, 2024
0
94
In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid—an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19—proved safe as an extended-duration ...
Jun 7, 2024
0
103
A website to support people living with long COVID is launched today, on Long COVID Awareness Day (March 15), by a research team led by a Southampton professor with first-hand experience of the condition.
Mar 15, 2024
0
44
New research by La Trobe University has uncovered the intricate relationship between two debilitating conditions, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID; offering insights into disease ...
Mar 6, 2024
0
40
SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in long COVID patients, IFN-y production persists until symptoms improve, ...
Feb 21, 2024
0
117
COVID vaccines will go on sale privately in England and Scotland from April 1 for all those aged 12 and over. In the US, they have been available to buy commercially since 2023, with the private sector already accounting ...
Feb 16, 2024
0
31
People with long COVID have dysfunctional immune cells that show signs of chronic inflammation and faulty movement into organs, among other unusual activity, according to a new study by scientists at Gladstone Institutes ...
Jan 11, 2024
0
122
A randomized controlled trial in Hong Kong finds that the synbiotic drug SIM01 relieves multiple symptoms of long COVID, or post-acute COVID-19 syndrome (PACS).
Dec 29, 2023
0
145
The WHO said Wednesday that COVID-19 deaths had dropped by 95 percent since the start of the year—but warned the virus was still on the move.
Apr 26, 2023
0
27
A team of medical professionals, clinicians, epidemiologists and political scientists recently published the results of a study that revealed new information about the prevalence of post-acute sequelae of SARS CoV-2 infection, ...
Nov 9, 2022
0
69
